Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
NIHR Journals Library
2009-06-01
|
| Series: | Health Technology Assessment |
| Online Access: | https://doi.org/10.3310/hta13suppl1/01 |
| _version_ | 1818127322742521856 |
|---|---|
| author | S Ward H Pilgrim D Hind |
| author_facet | S Ward H Pilgrim D Hind |
| author_sort | S Ward |
| collection | DOAJ |
| first_indexed | 2024-12-11T07:15:31Z |
| format | Article |
| id | doaj.art-2271f15df58245788bea0a5e317ad80e |
| institution | Directory Open Access Journal |
| issn | 1366-5278 2046-4924 |
| language | English |
| last_indexed | 2024-12-11T07:15:31Z |
| publishDate | 2009-06-01 |
| publisher | NIHR Journals Library |
| record_format | Article |
| series | Health Technology Assessment |
| spelling | doaj.art-2271f15df58245788bea0a5e317ad80e2022-12-22T01:16:14ZengNIHR Journals LibraryHealth Technology Assessment1366-52782046-49242009-06-0113Suppl 110.3310/hta13suppl1/0105/51/01Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisalS WardH PilgrimD Hindhttps://doi.org/10.3310/hta13suppl1/01 |
| spellingShingle | S Ward H Pilgrim D Hind Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal Health Technology Assessment |
| title | Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal |
| title_full | Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal |
| title_fullStr | Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal |
| title_full_unstemmed | Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal |
| title_short | Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal |
| title_sort | trastuzumab for the treatment of primary her2 positive breast cancer in her2 positive women a single technology appraisal |
| url | https://doi.org/10.3310/hta13suppl1/01 |
| work_keys_str_mv | AT sward trastuzumabforthetreatmentofprimaryher2positivebreastcancerinher2positivewomenasingletechnologyappraisal AT hpilgrim trastuzumabforthetreatmentofprimaryher2positivebreastcancerinher2positivewomenasingletechnologyappraisal AT dhind trastuzumabforthetreatmentofprimaryher2positivebreastcancerinher2positivewomenasingletechnologyappraisal |